Insider Transactions in Q4 2023 at Immunity Bio, Inc. (IBRX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2023
|
Richard Adcock CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
17,096
-7.77%
|
$85,480
$5.02 P/Share
|
|
Dec 31
2023
|
Richard Adcock CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
34,483
+13.55%
|
-
|
|
Dec 31
2023
|
David C. Sachs Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,511
-6.9%
|
$52,555
$5.02 P/Share
|
|
Dec 31
2023
|
David C. Sachs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,397
+16.63%
|
-
|
|
Dec 15
2023
|
Regan J Lauer Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,030
+21.91%
|
-
|